The global market for Invasive Neuromodulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Neuromodulation is a medical device that regulates and stimulates the activity of the nervous system. It is designed to provide a therapeutic effect by delivering electrical or chemical stimulation to specific areas of the body or to specific nerves. Neuromodulation devices are commonly used to treat a variety of neurological disorders and chronic pain that do not respond to traditional therapies.

The specific application and function of neuromodulation depends on the disease being treated and the target area of the nervous system. These devices are usually prescribed and implanted by medical professionals trained in neuromodulation therapy.

North American market for Invasive Neuromodulation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Invasive Neuromodulation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Invasive Neuromodulation in Parkinson's Disease is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Invasive Neuromodulation include Medtronic, Boston Scientific Corporation, Abbott, LivaNova, Cerbomed, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Invasive Neuromodulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Neuromodulation.

The Invasive Neuromodulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Invasive Neuromodulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Invasive Neuromodulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Invasive Neuromodulation Market Report

Report Metric	Details
Report Name	Invasive Neuromodulation Market
Segment by Type	Deep Brain Stimulator Vagus Nerve Stimulator Spinal Cord Stimulator Others
Segment by Application	Parkinson's Disease Epilepsy Migraine Depression Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic, Boston Scientific Corporation, Abbott, LivaNova, Cerbomed, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch, Nevro, Beijing Pins Medical, SceneRay, RISHENA, Znion HK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Invasive Neuromodulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Invasive Neuromodulation Market report?

Ans: The main players in the Invasive Neuromodulation Market are Medtronic, Boston Scientific Corporation, Abbott, LivaNova, Cerbomed, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch, Nevro, Beijing Pins Medical, SceneRay, RISHENA, Znion HK

What are the Application segmentation covered in the Invasive Neuromodulation Market report?

Ans: The Applications covered in the Invasive Neuromodulation Market report are Parkinson's Disease, Epilepsy, Migraine, Depression, Others

What are the Type segmentation covered in the Invasive Neuromodulation Market report?

Ans: The Types covered in the Invasive Neuromodulation Market report are Deep Brain Stimulator, Vagus Nerve Stimulator, Spinal Cord Stimulator, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Invasive Neuromodulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Deep Brain Stimulator

1.2.3 Vagus Nerve Stimulator

1.2.4 Spinal Cord Stimulator

1.2.5 Others

1.3 Market by Application

1.3.1 Global Invasive Neuromodulation Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Parkinson's Disease

1.3.3 Epilepsy

1.3.4 Migraine

1.3.5 Depression

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Invasive Neuromodulation Market Perspective (2020-2031)

2.2 Global Invasive Neuromodulation Growth Trends by Region

2.2.1 Global Invasive Neuromodulation Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Invasive Neuromodulation Historic Market Size by Region (2020-2025)

2.2.3 Invasive Neuromodulation Forecasted Market Size by Region (2026-2031)

2.3 Invasive Neuromodulation Market Dynamics

2.3.1 Invasive Neuromodulation Industry Trends

2.3.2 Invasive Neuromodulation Market Drivers

2.3.3 Invasive Neuromodulation Market Challenges

2.3.4 Invasive Neuromodulation Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Invasive Neuromodulation Players by Revenue

3.1.1 Global Top Invasive Neuromodulation Players by Revenue (2020-2025)

3.1.2 Global Invasive Neuromodulation Revenue Market Share by Players (2020-2025)

3.2 Global Invasive Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Invasive Neuromodulation Revenue

3.4 Global Invasive Neuromodulation Market Concentration Ratio

3.4.1 Global Invasive Neuromodulation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Invasive Neuromodulation Revenue in 2024

3.5 Global Key Players of Invasive Neuromodulation Head office and Area Served

3.6 Global Key Players of Invasive Neuromodulation, Product and Application

3.7 Global Key Players of Invasive Neuromodulation, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Invasive Neuromodulation Breakdown Data by Type

4.1 Global Invasive Neuromodulation Historic Market Size by Type (2020-2025)

4.2 Global Invasive Neuromodulation Forecasted Market Size by Type (2026-2031)

5 Invasive Neuromodulation Breakdown Data by Application

5.1 Global Invasive Neuromodulation Historic Market Size by Application (2020-2025)

5.2 Global Invasive Neuromodulation Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Invasive Neuromodulation Market Size (2020-2031)

6.2 North America Invasive Neuromodulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Invasive Neuromodulation Market Size by Country (2020-2025)

6.4 North America Invasive Neuromodulation Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Invasive Neuromodulation Market Size (2020-2031)

7.2 Europe Invasive Neuromodulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Invasive Neuromodulation Market Size by Country (2020-2025)

7.4 Europe Invasive Neuromodulation Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Invasive Neuromodulation Market Size (2020-2031)

8.2 Asia-Pacific Invasive Neuromodulation Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Invasive Neuromodulation Market Size by Region (2020-2025)

8.4 Asia-Pacific Invasive Neuromodulation Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Invasive Neuromodulation Market Size (2020-2031)

9.2 Latin America Invasive Neuromodulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Invasive Neuromodulation Market Size by Country (2020-2025)

9.4 Latin America Invasive Neuromodulation Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Invasive Neuromodulation Market Size (2020-2031)

10.2 Middle East & Africa Invasive Neuromodulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Invasive Neuromodulation Market Size by Country (2020-2025)

10.4 Middle East & Africa Invasive Neuromodulation Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medtronic

11.1.1 Medtronic Company Details

11.1.2 Medtronic Business Overview

11.1.3 Medtronic Invasive Neuromodulation Introduction

11.1.4 Medtronic Revenue in Invasive Neuromodulation Business (2020-2025)

11.1.5 Medtronic Recent Development

11.2 Boston Scientific Corporation

11.2.1 Boston Scientific Corporation Company Details

11.2.2 Boston Scientific Corporation Business Overview

11.2.3 Boston Scientific Corporation Invasive Neuromodulation Introduction

11.2.4 Boston Scientific Corporation Revenue in Invasive Neuromodulation Business (2020-2025)

11.2.5 Boston Scientific Corporation Recent Development

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Invasive Neuromodulation Introduction

11.3.4 Abbott Revenue in Invasive Neuromodulation Business (2020-2025)

11.3.5 Abbott Recent Development

11.4 LivaNova

11.4.1 LivaNova Company Details

11.4.2 LivaNova Business Overview

11.4.3 LivaNova Invasive Neuromodulation Introduction

11.4.4 LivaNova Revenue in Invasive Neuromodulation Business (2020-2025)

11.4.5 LivaNova Recent Development

11.5 Cerbomed

11.5.1 Cerbomed Company Details

11.5.2 Cerbomed Business Overview

11.5.3 Cerbomed Invasive Neuromodulation Introduction

11.5.4 Cerbomed Revenue in Invasive Neuromodulation Business (2020-2025)

11.5.5 Cerbomed Recent Development

11.6 Biocontrol Medical

11.6.1 Biocontrol Medical Company Details

11.6.2 Biocontrol Medical Business Overview

11.6.3 Biocontrol Medical Invasive Neuromodulation Introduction

11.6.4 Biocontrol Medical Revenue in Invasive Neuromodulation Business (2020-2025)

11.6.5 Biocontrol Medical Recent Development

11.7 Depuy Synthes Companies

11.7.1 Depuy Synthes Companies Company Details

11.7.2 Depuy Synthes Companies Business Overview

11.7.3 Depuy Synthes Companies Invasive Neuromodulation Introduction

11.7.4 Depuy Synthes Companies Revenue in Invasive Neuromodulation Business (2020-2025)

11.7.5 Depuy Synthes Companies Recent Development

11.8 Enteromedics

11.8.1 Enteromedics Company Details

11.8.2 Enteromedics Business Overview

11.8.3 Enteromedics Invasive Neuromodulation Introduction

11.8.4 Enteromedics Revenue in Invasive Neuromodulation Business (2020-2025)

11.8.5 Enteromedics Recent Development

11.9 Synapse Biomedical

11.9.1 Synapse Biomedical Company Details

11.9.2 Synapse Biomedical Business Overview

11.9.3 Synapse Biomedical Invasive Neuromodulation Introduction

11.9.4 Synapse Biomedical Revenue in Invasive Neuromodulation Business (2020-2025)

11.9.5 Synapse Biomedical Recent Development

11.10 Uroplasty

11.10.1 Uroplasty Company Details

11.10.2 Uroplasty Business Overview

11.10.3 Uroplasty Invasive Neuromodulation Introduction

11.10.4 Uroplasty Revenue in Invasive Neuromodulation Business (2020-2025)

11.10.5 Uroplasty Recent Development

11.11 Greatbatch

11.11.1 Greatbatch Company Details

11.11.2 Greatbatch Business Overview

11.11.3 Greatbatch Invasive Neuromodulation Introduction

11.11.4 Greatbatch Revenue in Invasive Neuromodulation Business (2020-2025)

11.11.5 Greatbatch Recent Development

11.12 Nevro

11.12.1 Nevro Company Details

11.12.2 Nevro Business Overview

11.12.3 Nevro Invasive Neuromodulation Introduction

11.12.4 Nevro Revenue in Invasive Neuromodulation Business (2020-2025)

11.12.5 Nevro Recent Development

11.13 Beijing Pins Medical

11.13.1 Beijing Pins Medical Company Details

11.13.2 Beijing Pins Medical Business Overview

11.13.3 Beijing Pins Medical Invasive Neuromodulation Introduction

11.13.4 Beijing Pins Medical Revenue in Invasive Neuromodulation Business (2020-2025)

11.13.5 Beijing Pins Medical Recent Development

11.14 SceneRay

11.14.1 SceneRay Company Details

11.14.2 SceneRay Business Overview

11.14.3 SceneRay Invasive Neuromodulation Introduction

11.14.4 SceneRay Revenue in Invasive Neuromodulation Business (2020-2025)

11.14.5 SceneRay Recent Development

11.15 RISHENA

11.15.1 RISHENA Company Details

11.15.2 RISHENA Business Overview

11.15.3 RISHENA Invasive Neuromodulation Introduction

11.15.4 RISHENA Revenue in Invasive Neuromodulation Business (2020-2025)

11.15.5 RISHENA Recent Development

11.16 Znion HK

11.16.1 Znion HK Company Details

11.16.2 Znion HK Business Overview

11.16.3 Znion HK Invasive Neuromodulation Introduction

11.16.4 Znion HK Revenue in Invasive Neuromodulation Business (2020-2025)

11.16.5 Znion HK Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Boston Scientific Corporation

Depuy Synthes Companies

List of Tables

Table 1. Global Invasive Neuromodulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Deep Brain Stimulator

Table 3. Key Players of Vagus Nerve Stimulator

Table 4. Key Players of Spinal Cord Stimulator

Table 5. Key Players of Others

Table 6. Global Invasive Neuromodulation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Invasive Neuromodulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Invasive Neuromodulation Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Invasive Neuromodulation Market Share by Region (2020-2025)

Table 10. Global Invasive Neuromodulation Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Invasive Neuromodulation Market Share by Region (2026-2031)

Table 12. Invasive Neuromodulation Market Trends

Table 13. Invasive Neuromodulation Market Drivers

Table 14. Invasive Neuromodulation Market Challenges

Table 15. Invasive Neuromodulation Market Restraints

Table 16. Global Invasive Neuromodulation Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Invasive Neuromodulation Market Share by Players (2020-2025)

Table 18. Global Top Invasive Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Neuromodulation as of 2024)

Table 19. Ranking of Global Top Invasive Neuromodulation Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Invasive Neuromodulation Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Invasive Neuromodulation, Headquarters and Area Served

Table 22. Global Key Players of Invasive Neuromodulation, Product and Application

Table 23. Global Key Players of Invasive Neuromodulation, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Invasive Neuromodulation Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Invasive Neuromodulation Revenue Market Share by Type (2020-2025)

Table 27. Global Invasive Neuromodulation Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Invasive Neuromodulation Revenue Market Share by Type (2026-2031)

Table 29. Global Invasive Neuromodulation Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Invasive Neuromodulation Revenue Market Share by Application (2020-2025)

Table 31. Global Invasive Neuromodulation Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Invasive Neuromodulation Revenue Market Share by Application (2026-2031)

Table 33. North America Invasive Neuromodulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Invasive Neuromodulation Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Invasive Neuromodulation Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Invasive Neuromodulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Invasive Neuromodulation Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Invasive Neuromodulation Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Invasive Neuromodulation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Invasive Neuromodulation Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Invasive Neuromodulation Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Invasive Neuromodulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Invasive Neuromodulation Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Invasive Neuromodulation Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Invasive Neuromodulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Invasive Neuromodulation Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Invasive Neuromodulation Market Size by Country (2026-2031) & (US$ Million)

Table 48. Medtronic Company Details

Table 49. Medtronic Business Overview

Table 50. Medtronic Invasive Neuromodulation Product

Table 51. Medtronic Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 52. Medtronic Recent Development

Table 53. Boston Scientific Corporation Company Details

Table 54. Boston Scientific Corporation Business Overview

Table 55. Boston Scientific Corporation Invasive Neuromodulation Product

Table 56. Boston Scientific Corporation Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 57. Boston Scientific Corporation Recent Development

Table 58. Abbott Company Details

Table 59. Abbott Business Overview

Table 60. Abbott Invasive Neuromodulation Product

Table 61. Abbott Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 62. Abbott Recent Development

Table 63. LivaNova Company Details

Table 64. LivaNova Business Overview

Table 65. LivaNova Invasive Neuromodulation Product

Table 66. LivaNova Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 67. LivaNova Recent Development

Table 68. Cerbomed Company Details

Table 69. Cerbomed Business Overview

Table 70. Cerbomed Invasive Neuromodulation Product

Table 71. Cerbomed Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 72. Cerbomed Recent Development

Table 73. Biocontrol Medical Company Details

Table 74. Biocontrol Medical Business Overview

Table 75. Biocontrol Medical Invasive Neuromodulation Product

Table 76. Biocontrol Medical Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 77. Biocontrol Medical Recent Development

Table 78. Depuy Synthes Companies Company Details

Table 79. Depuy Synthes Companies Business Overview

Table 80. Depuy Synthes Companies Invasive Neuromodulation Product

Table 81. Depuy Synthes Companies Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 82. Depuy Synthes Companies Recent Development

Table 83. Enteromedics Company Details

Table 84. Enteromedics Business Overview

Table 85. Enteromedics Invasive Neuromodulation Product

Table 86. Enteromedics Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 87. Enteromedics Recent Development

Table 88. Synapse Biomedical Company Details

Table 89. Synapse Biomedical Business Overview

Table 90. Synapse Biomedical Invasive Neuromodulation Product

Table 91. Synapse Biomedical Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 92. Synapse Biomedical Recent Development

Table 93. Uroplasty Company Details

Table 94. Uroplasty Business Overview

Table 95. Uroplasty Invasive Neuromodulation Product

Table 96. Uroplasty Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 97. Uroplasty Recent Development

Table 98. Greatbatch Company Details

Table 99. Greatbatch Business Overview

Table 100. Greatbatch Invasive Neuromodulation Product

Table 101. Greatbatch Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 102. Greatbatch Recent Development

Table 103. Nevro Company Details

Table 104. Nevro Business Overview

Table 105. Nevro Invasive Neuromodulation Product

Table 106. Nevro Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 107. Nevro Recent Development

Table 108. Beijing Pins Medical Company Details

Table 109. Beijing Pins Medical Business Overview

Table 110. Beijing Pins Medical Invasive Neuromodulation Product

Table 111. Beijing Pins Medical Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 112. Beijing Pins Medical Recent Development

Table 113. SceneRay Company Details

Table 114. SceneRay Business Overview

Table 115. SceneRay Invasive Neuromodulation Product

Table 116. SceneRay Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 117. SceneRay Recent Development

Table 118. RISHENA Company Details

Table 119. RISHENA Business Overview

Table 120. RISHENA Invasive Neuromodulation Product

Table 121. RISHENA Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 122. RISHENA Recent Development

Table 123. Znion HK Company Details

Table 124. Znion HK Business Overview

Table 125. Znion HK Invasive Neuromodulation Product

Table 126. Znion HK Revenue in Invasive Neuromodulation Business (2020-2025) & (US$ Million)

Table 127. Znion HK Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Invasive Neuromodulation Picture

Figure 2. Global Invasive Neuromodulation Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Invasive Neuromodulation Market Share by Type: 2024 VS 2031

Figure 4. Deep Brain Stimulator Features

Figure 5. Vagus Nerve Stimulator Features

Figure 6. Spinal Cord Stimulator Features

Figure 7. Others Features

Figure 8. Global Invasive Neuromodulation Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Invasive Neuromodulation Market Share by Application: 2024 VS 2031

Figure 10. Parkinson's Disease Case Studies

Figure 11. Epilepsy Case Studies

Figure 12. Migraine Case Studies

Figure 13. Depression Case Studies

Figure 14. Others Case Studies

Figure 15. Invasive Neuromodulation Report Years Considered

Figure 16. Global Invasive Neuromodulation Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Invasive Neuromodulation Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Invasive Neuromodulation Market Share by Region: 2024 VS 2031

Figure 19. Global Invasive Neuromodulation Market Share by Players in 2024

Figure 20. Global Top Invasive Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Neuromodulation as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Invasive Neuromodulation Revenue in 2024

Figure 22. North America Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Invasive Neuromodulation Market Share by Country (2020-2031)

Figure 24. United States Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Invasive Neuromodulation Market Share by Country (2020-2031)

Figure 28. Germany Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Invasive Neuromodulation Market Share by Region (2020-2031)

Figure 36. China Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Invasive Neuromodulation Market Share by Country (2020-2031)

Figure 44. Mexico Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Invasive Neuromodulation Market Share by Country (2020-2031)

Figure 48. Turkey Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Invasive Neuromodulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Medtronic Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 52. Boston Scientific Corporation Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 53. Abbott Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 54. LivaNova Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 55. Cerbomed Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 56. Biocontrol Medical Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 57. Depuy Synthes Companies Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 58. Enteromedics Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 59. Synapse Biomedical Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 60. Uroplasty Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 61. Greatbatch Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 62. Nevro Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 63. Beijing Pins Medical Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 64. SceneRay Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 65. RISHENA Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 66. Znion HK Revenue Growth Rate in Invasive Neuromodulation Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4R20263

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Online Speech Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39V19943

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Nerve Repair and Regeneration Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-10C17235

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Neurological Disease Model Chip Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-7M17348

Thu Nov 06 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Invasive Neuromodulation Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-24H16160

Global Invasive Neuromodulation Market Research Report 2025

FEATURED COMPANIES

Invasive Neuromodulation Market

Scope of Invasive Neuromodulation Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Invasive Neuromodulation Market report?

What are the Application segmentation covered in the Invasive Neuromodulation Market report?

What are the Type segmentation covered in the Invasive Neuromodulation Market report?

FEATURED COMPANIES

RELATED REPORTS